HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa.

Abstract
To study the natural history of rotavirus infection and to determine the protection it confers against reinfection and diarrhea, 200 newborns in Guinea-Bissau were prospectively followed for up to 2 years. Rotavirus was detected in stool specimens collected weekly. By age 2 years, the incidence of primary rotavirus infection was 74%. In the first 3 months of life, 17% of the infections were diarrhea associated, compared with 60% at 9-11 months; after age 18 months, all infections were asymptomatic. A primary infection conferred 52% (95% confidence interval [CI], 16% to 73%) and 70% (95% CI, 29% to 87%) protection against subsequent rotavirus infection and rotavirus diarrhea, respectively. The protection was 66% (95% CI, 24% to 85%) against reinfection within the same epidemic, compared with 34% (95% CI, -29% to 67%) against reinfection in any subsequent epidemic. The high level of protection against symptomatic rotavirus infection provides an important incentive for development of a rotavirus vaccine.
AuthorsThea K Fischer, Palle Valentiner-Branth, Hans Steinsland, Michael Perch, Gina Santos, Peter Aaby, Kåre Mølbak, Halvor Sommerfelt
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 186 Issue 5 Pg. 593-7 (Sep 01 2002) ISSN: 0022-1899 [Print] United States
PMID12195345 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Cohort Studies
  • Diarrhea (epidemiology, immunology, virology)
  • Feces (microbiology)
  • Female
  • Guinea-Bissau (epidemiology)
  • Humans
  • Immunity, Innate (immunology)
  • Incidence
  • Infant, Newborn
  • Logistic Models
  • Male
  • Rotavirus (immunology)
  • Rotavirus Infections (epidemiology, immunology, virology)
  • Seasons

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: